Difference between revisions of "TFE3-rearranged renal cell carcinoma"

Jump to navigation Jump to search
Line 80: Line 80:
==Molecular==
==Molecular==
*[[Translocation]] involving TFE3.
*[[Translocation]] involving TFE3.
**The most common are:<ref name=pmid24309327 >{{Cite journal  | last1 = Ellis | first1 = CL. | last2 = Eble | first2 = JN. | last3 = Subhawong | first3 = AP. | last4 = Martignoni | first4 = G. | last5 = Zhong | first5 = M. | last6 = Ladanyi | first6 = M. | last7 = Epstein | first7 = JI. | last8 = Netto | first8 = GJ. | last9 = Argani | first9 = P. | title = Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stage. | journal = Mod Pathol | volume =  | issue =  | pages =  | month = Dec | year = 2013 | doi = 10.1038/modpathol.2013.208 | PMID = 24309327 }}</ref>
 
***t(X;1)(p11.2;q21) PRCC-TFE3.<ref name=Ref_WMSP285>{{Ref WMSP|285}}</ref>
The most common are:<ref name=pmid24309327 >{{Cite journal  | last1 = Ellis | first1 = CL. | last2 = Eble | first2 = JN. | last3 = Subhawong | first3 = AP. | last4 = Martignoni | first4 = G. | last5 = Zhong | first5 = M. | last6 = Ladanyi | first6 = M. | last7 = Epstein | first7 = JI. | last8 = Netto | first8 = GJ. | last9 = Argani | first9 = P. | title = Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stage. | journal = Mod Pathol | volume =  | issue =  | pages =  | month = Dec | year = 2013 | doi = 10.1038/modpathol.2013.208 | PMID = 24309327 }}</ref>
***t(X;17)(p11;q25) ASPSCR1-TFE3.
*t(X;1)(p11.2;q21) PRCC-TFE3.<ref name=Ref_WMSP285>{{Ref WMSP|285}}</ref>
*t(X;17)(p11;q25) ASPSCR1-TFE3.
**Also seen in [[alveolar soft part sarcoma]].


==See also==
==See also==
48,466

edits

Navigation menu